Loading...
XTAI
4148
Market cap100mUSD
May 09, Last price  
47.10TWD
1D
0.00%
1Q
-1.98%
IPO
-35.57%
Name

All Cosmos Bio-Tech Holding Corp

Chart & Performance

D1W1MN
P/E
23.45
P/S
1.23
EPS
2.01
Div Yield, %
2.12%
Shrs. gr., 5y
0.27%
Rev. gr., 5y
6.82%
Revenues
2.46b
-13.02%
1,404,531,0001,804,681,0001,874,852,0002,231,231,0002,257,308,0002,065,543,0002,263,652,0002,687,581,0001,767,699,0001,642,783,0002,197,323,0003,702,330,0002,826,587,0002,458,636,000
Net income
129m
-7.73%
162,321,000210,360,000158,476,000195,639,000197,064,000243,217,000322,873,000305,058,00035,694,00082,204,000198,128,000368,204,000139,361,000128,588,000
CFO
54m
-94.35%
138,047,000194,852,00041,583,00097,034,000145,766,000507,381,000176,120,000-218,333,000883,558,000-126,878,000-67,643,00043,843,000959,243,00054,186,000
Dividend
Jul 11, 20241 TWD/sh

Profile

All Cosmos Bio-Tech Holding Corporation, through its subsidiaries, manufactures and sells bio-organic and bio-chemical compound fertilizers in Malaysia. It also engages in the research and development of microorganisms for waste disposal of oil-palm; and wholesale of probiotics. In addition, the company is involved in the research and forest plantation activities. It also exports its products to Taiwan, Indonesia, Vietnam, and China. All Cosmos Bio-Tech Holding Corporation was founded in 1999 and is headquartered in George Town, the Cayman Islands.
URL
https://www.allcosmos.com/en/
IPO date
Jun 08, 2017
Employees
Domiciled in
MY
Incorporated in
KY

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,458,636
-13.02%
2,826,587
-23.65%
3,702,330
68.49%
Cost of revenue
2,294,924
2,638,691
3,042,599
Unusual Expense (Income)
NOPBT
163,712
187,896
659,731
NOPBT Margin
6.66%
6.65%
17.82%
Operating Taxes
78,280
68,321
177,931
Tax Rate
47.82%
36.36%
26.97%
NOPAT
85,432
119,575
481,800
Net income
128,588
-7.73%
139,361
-62.15%
368,204
85.84%
Dividends
(64,034)
(160,085)
(96,051)
Dividend yield
2.05%
4.58%
2.71%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
243,638
513,206
406,641
Long-term debt
26,053
39,728
540,132
Deferred revenue
533,821
Other long-term liabilities
673
669
(533,821)
Net debt
(696,939)
(1,126,438)
(424,901)
Cash flow
Cash from operating activities
54,186
959,243
43,843
CAPEX
(139,699)
(162,750)
(60,859)
Cash from investing activities
(228,456)
(202,979)
(4,668)
Cash from financing activities
(428,493)
(549,882)
490,389
FCF
(356,653)
728,163
(80,555)
Balance
Cash
1,249,680
1,657,029
1,468,195
Long term investments
(283,050)
22,343
(96,521)
Excess cash
843,698
1,538,043
1,186,558
Stockholders' equity
1,907,548
1,890,287
2,087,245
Invested Capital
2,548,890
1,819,910
2,561,538
ROIC
3.91%
5.46%
21.04%
ROCE
4.77%
5.53%
17.46%
EV
Common stock shares outstanding
64,963
70,766
66,041
Price
48.00
-2.74%
49.35
-8.10%
53.70
33.92%
Market cap
3,118,227
-10.71%
3,492,302
-1.53%
3,546,402
37.74%
EV
3,036,359
2,925,715
3,617,777
EBITDA
217,691
237,043
708,743
EV/EBITDA
13.95
12.34
5.10
Interest
6,083
3,983
18,810
Interest/NOPBT
3.72%
2.12%
2.85%